# Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

> **NCT00003412** · PHASE1 · UNKNOWN · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 35 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** recombinant interleukin-12

## Key facts

- **NCT ID:** NCT00003412
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003412, "Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*